Cargando…
Transcriptomic Research in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives
Heart failure with preserved ejection fraction (HFpEF) is increasing in incidence and has a higher prevalence compared with heart failure with reduced ejection fraction. So far, no effective treatment of HFpEF is available, due to its complex underlying pathophysiology and clinical heterogeneity. Th...
Autores principales: | Rosch, Sebastian, Rommel, Karl-Philipp, Scholz, Markus, Thiele, Holger, Lurz, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539142/ https://www.ncbi.nlm.nih.gov/pubmed/33042584 http://dx.doi.org/10.15420/cfr.2019.19 |
Ejemplares similares
-
Suppression of Tumourigenicity 2 in Heart Failure With Preserved Ejection Fraction
por: Zach, Veronika, et al.
Publicado: (2020) -
Deep learning detects heart failure with preserved ejection fraction using a baseline electrocardiogram
por: Unterhuber, Matthias, et al.
Publicado: (2021) -
Sympathomodulation in Heart Failure with High vs. Normal Ejection Fraction
por: Fengler, Karl, et al.
Publicado: (2022) -
Evaluation of phosphodiesterase 9A as a novel biomarker in heart failure with preserved ejection fraction
por: Besler, Christian, et al.
Publicado: (2021) -
Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trials
por: Kresoja, Karl-Patrik, et al.
Publicado: (2023)